Noncompliance with antihypertensive medications
The impact of depressive symptoms and psychosocial factors
10.1046/j.1525-1497.2002.00406.x Cite this article as: Wang, P.S., Bohn, R.L., Knight, E. et al. J GEN INTERN MED (2002) 17: 504. doi:10.1046/j.1525-1497.2002.00406.x Abstract OBJECTIVE: Addressing the epidemic of poor compliance with antihypertensive medications will require identifying factors associated with poor adherence, including modifiable psychosocial and behavioral characteristics of patients. DESIGN: Cross-sectional study, comparing measured utilization of antihypertensive prescriptions with patients’ responses to a structured interview. STUDY POPULATION: Four hundred ninety-six treated hypertensive patients drawn from a large HMO and a VA medical center. DATA COLLECTION: We developed a survey instrument to assess patients’ psychosocial and behavioral characteristics, including health beliefs, knowledge, and social support regarding blood pressure medications, satisfaction with health care, depression symptom severity, alcohol consumption, tobacco use, and internal versus external locus of control. Other information collected included demographic and clinical characteristics and features of antihypertensive medication regimens. All prescriptions filled for antihypertensive medications were used to calculate actual adherence to prescribed regimens in a 365-day study period. MAIN OUTCOME OF INTEREST: Adjusted odds ratios (ORs) of antihypertensive compliance, based on ordinal logistic regression models. RESULTS: After adjusting for the potential confounding effects of demographic, clinical, and other psychosocial variables, we found that depression was significantly associated with noncompliance (adjusted OR per each point increase on a 14-point scale, 0.93; 95% confidence interval [95% CI], 0.87 to 0.99); in unadjusted analyses, the relationship did not reach statistical significance. There was also a trend toward improved compliance for patients perceiving that their health is controlled by external factors (adjusted OR per point increase, 1.14; 95% CI, 0.99 to 1.33). There was no association between compliance and knowledge of hypertension, health beliefs and behaviors, social supports, or satisfaction with care. CONCLUSIONS: Depressive symptoms may be an under-recognized but modifiable risk factor for poor compliance with antihypertensive medications. Surprisingly, patient knowledge of hypertension, health beliefs, satisfaction with care, and other psychosocial variables did not appear to consistently affect adherence to prescribed regimens. Key words antihypertensive medication adherence depressive symptoms psychosocial factors
Received from the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School Boston, Mass.
This work was supported by a research grant from the Outcomes Research Department of Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Wang is the recipient of a training grant from the National Institute of Mental Health (K01-MH0165-01).
Burt V, Whelton P, Roccells E, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–13.
Sharkness CM, Snow DA. The patient’s view of hypertension and compliance. Am J Prev Med. 1992;8:141–6.
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86:1805–8.
Clark T. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664–9.
Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician. 1998;57:1007–14.
Setaro J, Black H. Refractory hypertension. N Engl J Med. 1992;327:543–7.
Sackett D, Haynes R, Gibson E, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;7918:1205–7.
The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–44.
Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor D, Sackett D, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979.
Klein LE. Compliance and blood pressure control. Hypertension. 1988;11:II61–4.
Costa FV. Compliance with anthihypertensive treatment. Clin Exp Hypertens. 1996;18:463–72.
Bailey JE, Lee MD, Somes GW, Graham RL. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther. 1996;18:1252–62.
McClellan W, Hall W, Brogan D, Miles C, Wilber J. Continuity of care in hypertension. Arch Intern Med. 1988;148:525–8.
Balazovjech I, Hnilica P Jr. Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens. 1993;7:581–3.
Shaw E, Anderson J, Maloney M, Jay S, Fagan D. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm. 1995;30:201–7.
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance. Am J Hypertens. 1997;10:697–704.
Haynes RB, Mattson M, Chobanian A, et al. Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group. Hypertension. 1982;4:415–23.
Haynes RB. A critical review of the “determinants” of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB, eds. Compliance with Therapeutic Regimens, Johns Hopkins University Press; 1976.
Norman SA, Marconi KM, Schezel GW, Schechter CF, Stolley PD. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med. 1985;1:10–7.
Haines C, Ward G. Recent trends in public knowledge, attitudes, and reported behavior with respect to high blood pressure. Public Health Rep. 1981;96:515–22.
Earp J, Ory M. The effects of social support and health professional home visits on patient adherence to hypertension regimens. Prev Med. 1979;8:155–62.
Nelson E, Stason W, Neutra R, Solomon H. Identification of the noncompliant hypertensive patient. Prev Med. 1980;9:504–17.
Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol. 1995;18:(6 suppl 3)12–6.
Baksaas I, Helgeland A. Patient reaction to information and motivation factors in long-term treatment with antihypertensive drugs. Acta Med Scand. 1980;207:407–12.
Hershey JC, Morton BG, Braithwaite Davis J, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health. 1980;70:1081–9.
Volicer B, Volicer L. Randomized response technique for estimating alcohol use and noncompliance in hypertensives. J Stud Alcohol. 1982;43:739–50.
Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88–90.
Derogatis L, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595–605.
Rudnick K, Sackett D, Hirst S, Holmes C. Hypertension in a family practice. Can Med Assoc J. 1977;117:492–7.
Levine D, Gren L, Deeds S, Chwalow J, Russell P, Finlay J. Health education for hypertensive patients. JAMA. 1979;241:1700–3.
Rotter J. Some problems and misconceptions related to the construct of internal versus external control of reinforcement. J Consult Clin Psychol. 1975;43:56–67.
Marlowe D, Crowne DP. Social desirability and response to perceived situation demands. J Consult Psychol. 1961;25:109–15.
Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993; 83:711–6.
Avorn J, Monette J, Lacour A, et al. Persistance of use of lipid-lowering medications. JAMA. 1998;279:1458–62.
Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265–8.
Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the hypertension detection follow-up program. JAMA. 1979;242:2562–77.
SAS User’s Guide. Version 6.12. SAS Institute, Cary, N.C., 1998.
Avorn J, Everitt D, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986;225:357–60.
Morgado A, Raoux N, Smith M, Allilaire J, Widlocher D. Subjective bias in reports of poor work adjustment in depressed patients. Acta Psychiatr Scand. 1989;80:541–7.
Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261–9.
Kiley D, Lam C, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993;55:51–6.
Bosley C, Fosbury J, Cochrane G. The psychological factors associated with poor adherence with treatment for asthma. Eur Respir J. 1995;8:899–904.
Meichenbaum D, Turk D. Facilitating Treatment Adherence. New York: Plenum; 1987.
Col N, Fanale J, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841–5.
Conn V, Taylor S, Abele P. Myocardial infarction survivors: age and gender differences in physical health, psychosocial state, and regimen adherence. J Adv Nurs. 1991;16:1026–34.
Waxman HM, McCreary G, Weinrit RM, Carner EA. A comparison of somatic complaints among depressed and nondepressed older patients. Gerontologist. 1987;85:501–7.
Marks G, Richardson J, Graham J, Levine A. Role of health locus of control beliefs and expectations of treatment efficacy in adjustment to cancer. J Pers Soc Psychol. 1986;51:443–50.
Bursten B. Medication nonadherence due to feelings of loss of control in “biological depression.” Am J Psychiatry. 1985;142:244–6.
Ley P. Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens. 1985;3(suppl 1):51–5.
Carney R, Rich M, Freedland K, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50:627–33.
Carney R, Rich M, teVelde A, Saini J, Clark K, Jaffe A. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273–5.
Wassertheil-Smoller S, Applegate W, Berge K, et al. Change in depression as a precursor of cardiovascular events. Arch Intern Med. 1996;156:553–61.
Bruce M, Leaf P. Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health. 1989;79:727–30.
Rabins P, Harvis K, Koven S. High fatality rates of late life depression associated with cardiovascular disease. J Affect Disord. 1985;9:165–7.
Hirschfeld R, Keller M, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333–40.
Katz SJ, Kessler RC, Lin E, Wells KB. Medication management of depression in the United States and Ontario. J Gen Intern Med. 1998;13:77–85.
Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284–92.
Mohr D, Goodkin D, Likosky W, Gatto N, Baumann K, Rudick R. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997;54:531–3.
Lustman P, Griffith L, Freedland K, Kissel S, Clouse R. Cognitive behavior therapy for depression in type 2 diabetes mellitus. Ann Intern Med. 1998;129:613–21.
Eastaugh S, Hatcher M. Improving compliance among hypertensives: a triage criterion with cost-benefit implications. Med Care. 1982;20:1001–17.
PubMed CrossRef Copyright information
© Society of General Internal Medicine 2002